Tecnis Symfony OptiBlue Lens for Cataracts

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Coastal Eye Surgeons PLLC

No Placebo Group

Trial Summary

What is the purpose of this trial?Tecnis Symfony Optiblue EDOF IOL is the latest version of Tecnis Symfony IOL with a violet light filter (VLF), which blocks short-wavelength light and improves the quality of vision while minimizing visual disturbances. The present study aims to assess the visual outcomes at distance, intermediate, and near following cataract surgery and implantation of Tecnis Symfony Optiblue IOL in patients with retinal comorbidities.

Eligibility Criteria

This trial is for individuals undergoing cataract surgery who wish to improve their vision at various distances. It's specifically testing a new type of lens implant that filters certain light wavelengths. Patients with additional eye conditions affecting the retina may also participate.

Inclusion Criteria

I have eye conditions but can see well enough and agree to follow study rules for cataract surgery.

Exclusion Criteria

I have weak eye ligaments.

I have been diagnosed with keratoconus.

I have a severe form of diabetic eye disease.

+13 more

Participant Groups

The study is evaluating the Tecnis Symfony OptiBlue and its toric version, which are advanced lens implants designed to enhance vision after cataract removal by filtering violet light and reducing visual disturbances.

1Treatment groups

Experimental Treatment

Group I: Tecnis Symfony OptiBlue/ Tecnis Symfony OptiBlue toric IOLExperimental Treatment1 Intervention

This prospective, non-comparative, interventional study will include 15 cataract patients (30 eyes) who will undergo femtosecond laser-assisted cataract surgery with implantation of the Tecnis Symfony OptiBlue/ Tecnis Symfony OptiBlue toric IOL in both eyes.